Kolexia
Chéneau Caroline Oncologie médicale
Chéneau Caroline
Oncologie médicale
Sgsm Onco
Cesson-Sévigné, France
62 Activités
114 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Gliome Tumeurs de la prostate Glioblastome Tumeurs prostatiques résistantes à la castration Cardiotoxicité Fatigue Récidive tumorale locale Carcinomes Néphrocarcinome

Collaborateurs

Voir plus
Bera Guillaume
Bera Guillaume
Hôpital du Scorff, Lorient, France
Graziana Jean-Pierre
Graziana Jean-Pierre
Clinique Mutualiste Porte De L'orient, Lorient, France
Cumin Isabelle
Cumin Isabelle
Hôpital du Scorff, Lorient, France
Lamy Regine
Lamy Regine
Hôpital du Scorff, Lorient, France

Industries

Voir plus
B3TSI
20 collaboration(s)
Dernière en 2021
A+A
12 collaboration(s)
Dernière en 2023
Sanofi
7 collaboration(s)
Dernière en 2021
BMS
6 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial.
European urology   14 novembre 2021
Efficacy of AI and palbociclib in ER+ HER2- advanced breast cancer patients relapsing during adjuvant tamoxifen: An exploratory analysis of the PADA-1 trial.
2021 ASCO Annual Meeting I   28 mai 2021
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
International journal of cancer   01 août 2019
A Cost-Utility Analysis Comparing Two Sequences of Treatment for First-Line Chemotherapy in Metastatic Prostate Cancer (MCRPC): Cabazitaxel Followed by Docetaxel Versus Docetaxel Followed by Cabazitaxel
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research   01 octobre 2017
Patient preference between Cabazitaxel and Docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC): Results from the CABADOC randomized trial
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
CABA-DOC: A Study of Patient Preference Between Cabazitaxel and Docetaxel in First-line Chemotherapy for Metastatic Castrate-resistant Prostate Cancer
Essai Clinique (Sanofi)   07 août 2017
Trastuzumab induced cardiotoxicity in HER2-positive metastatic esogastric cancers.
2016 Gastrointestinal Cancers Symposium   01 février 2016
Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma.
Cancer investigation   06 janvier 2016
P-086 Trastuzumab induced cardiotoxicity in Her2 positive metastatic oeso-gastric cancers
ESMO 17th World Congress on Gastrointestinal Cancer, 1-4 July 2015, Barcelona, Spain   01 juin 2015
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.
Journal of neuro-oncology   07 décembre 2014